Scherer, Antonia; Dufour, Jean-François (2016). Treatment of Non-Alcoholic Fatty Liver Disease. Digestive diseases, 34(Suppl. 1), pp. 27-31. Karger 10.1159/000447278
|
Text
Treatment of Non-Alcoholic Fatty.pdf - Published Version Available under License Publisher holds Copyright. Download (76kB) | Preview |
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions from steatosis to cirrhosis and hepatocellular carcinoma. Steatosis is a benign reversible condition, which does not need treatment. Cirrhosis and hepatocellular carcinoma are the end stages of any chronic liver disease and do not have etiology-specific treatments. In this chapter, we will review treatment options for non-alcoholic steatohepatitis, which is the progressive form of NAFLD. Basically there are 2 strategies, the first of which is to address lifestyle and the second to use medication. The first approach is the most physiologic, the least expensive, but is also the most difficult to implement. The second approach, which should help patients who failed the first approach, is at the advanced clinical research stage.
Item Type: |
Journal Article (Review Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie |
UniBE Contributor: |
Dufour, Jean-François |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0257-2753 |
Publisher: |
Karger |
Language: |
English |
Submitter: |
Lilian Karin Smith-Wirth |
Date Deposited: |
05 Apr 2017 11:16 |
Last Modified: |
05 Dec 2022 15:01 |
Publisher DOI: |
10.1159/000447278 |
PubMed ID: |
27548081 |
BORIS DOI: |
10.7892/boris.93545 |
URI: |
https://boris.unibe.ch/id/eprint/93545 |